Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Resectable Carcinoma”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Testing effectiveness (Phase 2)UnknownNCT04202809
What this trial is testing

Phase-II Trial of Induction Chemotherapy and Chemoradiotherapy Plus/Minus Durvalumab and Consolidation Immunotherapy in Patients With Resectable Stage III NSCLC.

Who this might be right for
NSCLC, Stage III
University Hospital, Essen 90
Testing effectiveness (Phase 2)Looking for participantsNCT04302025
What this trial is testing

Multiple Therapies in Biomarker-selected Participants With Resectable Stages IB-III Non-small Cell Lung Cancer (NSCLC)

Who this might be right for
Non-small Cell Lung Cancer
Genentech, Inc. 99
Not applicableLooking for participantsNCT05327517
What this trial is testing

Surgery or Chemoradiotherapy for Cervical Esophageal Cancer

Who this might be right for
Cervical Esophageal Cancer
Cancer Institute and Hospital, Chinese Academy of Medical Sciences 192
Not applicableStudy completedNCT03001596
What this trial is testing

Comparison Between NCRT and NCT Followed by MIE for Treatment of Locally Advanced Resectable ESCC

Who this might be right for
Esophageal Squamous Cell Carcinoma Stage cT3-4aN0-1M0
Shanghai Zhongshan Hospital 264
Not applicableActive Not RecruitingNCT07009470
What this trial is testing

A Multicenter, Prospective Study of Perioperative Finotonlimab Combined With Bevacizumab in Resectable Hepatocellular Carcinoma Patients With High-Risk Factors for Recurrence

Who this might be right for
HCC
Tongji Hospital 130
Not applicableStudy completedNCT03381651
What this trial is testing

Different Radiation Dose of Neoadjuvant Chemoradiation for Resectable Thoracic Esophageal Squamous Carcinoma

Who this might be right for
Esophageal CarcinomaNeoadjuvant ChemoradiotherapySurgery
Zhejiang Cancer Hospital 147
Testing effectiveness (Phase 2)Looking for participantsNCT06897046
What this trial is testing

Perioperative Study of Iparomlimab and Tuvonralimab in Resectable NSCLC

Who this might be right for
Non-small Cell Lung Cancer (NSCLC)II-IIIB
Cancer Institute and Hospital, Chinese Academy of Medical Sciences 90
Large-scale testing (Phase 3)Active Not RecruitingNCT06632327
What this trial is testing

Comparing Impact of Treatment Before or After Surgery in Patients With Stage II-IIIB Resectable Non-small Cell Lung Cancer

Who this might be right for
Resectable Lung Non-Small Cell CarcinomaStage II Lung Cancer AJCC v8Stage IIIA Lung Cancer AJCC v8+1 more
Alliance for Clinical Trials in Oncology 37
Testing effectiveness (Phase 2)Study completedNCT01635270
What this trial is testing

Phase 2 Study Evaluating Mid-position Strategy in Radiotherapy Treatment for Patients With a Locally Advanced Non-small Cell Lung Carcinoma

Who this might be right for
Non-small Cell Lung CancerRadiation TherapyLocally Advanced Disease+2 more
Centre Leon Berard 54
Testing effectiveness (Phase 2)Ended earlyNCT05908786
What this trial is testing

A Study Evaluating The Efficacy and Safety of Neoadjuvant Immunotherapy Combinations in Patients With Surgically Resectable Hepatocellular Carcinoma

Who this might be right for
Carcinoma, Hepatocellular
Hoffmann-La Roche 62
Large-scale testing (Phase 3)Active Not RecruitingNCT02758951
What this trial is testing

Perioperative Systemic Therapy for Isolated Resectable Colorectal Peritoneal Metastases

Who this might be right for
Colorectal NeoplasmColorectal CancerColorectal Neoplasms Malignant+8 more
Koen Rovers 358
Testing effectiveness (Phase 2)Looking for participantsNCT07324824
What this trial is testing

Sintilimab Plus Bevacizumab Biosimilar as Neoadjuvant Therapy for Resectable Hepatocellular Carcinoma

Who this might be right for
Hepatocellular CarcinomaNeoadjuvant TherapySintilimab+1 more
Sun Yat-sen University 37
Not applicableUnknownNCT02958059
What this trial is testing

Effectiveness of Prophylactic Antibiotics to Prevent Post Endoscopic Retrograde Cholangio Pancreatography Bacteremia in Biliary Obstruction Patient

Who this might be right for
Biliary Obstructive Disease Such as CholedocholithiasisBenign Biliary StricturePeri-ampullary Cancer+2 more
Yonsei University 400
Not applicableStudy completedNCT05619562
What this trial is testing

Clinical Significance of Circulating Tumour Cells in Resectable Lung Cancer Patients

Who this might be right for
Non Small Cell Lung CancerCirculating Tumor Cell
The Institute of Molecular and Translational Medicine, Czech Republic 166
Testing effectiveness (Phase 2)Looking for participantsNCT04933903
What this trial is testing

BrUOG 397: NEO Rad (LOW): Neoadjuvant Low Dose Stereotactic Body Radiotherapy, Ipilimumab and Nivolumab

Who this might be right for
Non Small Cell Lung Cancer
Brown University 25
Not applicableActive Not RecruitingNCT05459415
What this trial is testing

Reducing Excision Margins After Neoadjuvant Chemoimmunotherapy for HPV Negative Resectable Locally Advanced HNSCC

Who this might be right for
Squamous Cell Carcinoma of Head and NeckNeoadjuvant TherapyResection Margin
Union Hospital, Tongji Medical College, Huazhong University of Science and Technology 54
Not applicableUnknownNCT06267144
What this trial is testing

Detection of Minimal Residual Disease in Resectable Stage II-IIIB Non-small Cell Lung Cancer

Who this might be right for
Lung Cancer
The First Hospital of Jilin University 20
Not applicableNot Yet RecruitingNCT07326189
What this trial is testing

Preoperative Right Hepatic Artery Embolization for Locally Advanced Bismuth IIIb and IV Perihilar Cholangiocarcinoma

Who this might be right for
Cholangiocarcinoma Non-resectable
Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University 33
Testing effectiveness (Phase 2)Not Yet RecruitingNCT07493993
What this trial is testing

Clinical Study on the Efficacy and Safety of Iparomlimab and Tuvonralimab Injection Combined With Nab-Paclitaxel in Neoadjuvant Therapy for Locally Advanced Resectable Esophageal Squamous Cell Carcinoma

Who this might be right for
ESCC
Tianjin Medical University Cancer Institute and Hospital 26
Post-approval studies (Phase 4)Not Yet RecruitingNCT06311916
What this trial is testing

Efficacy and Safety of Neoadjuvant Therapy in Patients With Resectable HCC Screened by a Multimodal Deep Learning Model.

Who this might be right for
HCC
Chen Xiaoping 312
Next Page